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Abstract 54 
The activity-regulated cytoskeleton-associated (Arc) protein control synaptic strength by 55 
facilitating AMPA receptor (AMPAR) endocytosis. Here we demonstrate that Arc targets 56 
AMPAR to be internalized through a direct interaction with the clathrin-adaptor protein 2 (AP-57 
2). We show that Arc overexpression overexpression in dissociated hippocampal neurons 58 
obtained from C57BL/6 mouse reduces the density of AMPAR GluA1 subunits at the cell 59 
surface and reduces the amplitude and rectification of AMPAR-mediated miniature-excitatory 60 
postsynaptic currents (mEPSC). Mutations of Arc, that prevent the AP-2 interaction reduce 61 
Arc-mediated endocytosis of GluA1 and abolish the reduction in AMPAR-mediated mEPSC 62 
amplitude and rectification. Depletion of the AP-2 subunit µ2 blocks the Arc-mediated 63 
reduction in mEPSC amplitude, effect that is restored by re-introducing µ2. The Arc/AP-2 64 
interaction plays an important role in homeostatic synaptic scaling as the Arc-dependent 65 
decrease in mEPSC amplitude, induced by a chronic increase in neuronal activity, is 66 
inhibited by AP-2 depletion. This data provides a mechanism to explain how activity-67 
dependent expression of Arc decisively controls the fate of AMPAR at the cell surface and 68 
modulates synaptic strength, via the direct interaction with the endocytic clathrin adaptor AP-69 
2. 70 
 71 
Significance Statement 72 
The direct binding of Arc to the clathrin-adaptor protein 2 complex discovered in this study 73 
provides the crucial mechanistic link between the activity-dependent expression of Arc and 74 
the targeting of specific synaptic AMPA receptors for endocytosis. The interaction between 75 
Arc and AP-2 is crucial for many forms of synaptic plasticity and may provide a novel target 76 
for therapeutic intervention. 77 
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 78 
Introduction 79 
Activity-dependent long-lasting alterations in glutamatergic synaptic strength are the 80 
molecular substrate thought to underlie learning and memory. The establishment and 81 
maintenance of changes in synaptic strength is dependent on trafficking of AMPAR at the 82 
postsynaptic membrane (Ehlers, 2000; Newpher and Ehlers, 2008), together with changes in 83 
protein synthesis (Buffington et al., 2014). In recent years, several neuron specific immediate 84 
early genes (IEGs) that are rapidly induced in response to neuronal activity have been 85 
described (Flavell and Greenberg, 2008), including Arc, also named activity-regulated gene 86 
of 3.1 kb (Arg3.1). Following neuronal activation, Arc mRNA is rapidly trafficked to 87 
postsynaptic dendritic sites and locally translated (Lyford et al., 1995; Steward et al., 1998). 88 
A rapid increase in Arc protein expression regulates synaptic strength, mainly by enhancing 89 
the endocytosis of AMPAR at postsynaptic sites (Rial Verde et al., 2006; Shepherd et al., 90 
2006; Waung et al., 2008; Mabb et al., 2014). A number of studies have shown that Arc 91 
regulates several forms of synaptic plasticity, including homeostatic scaling (Shepherd et al., 92 
2006; Corrêa et al., 2012; Mabb et al., 2014) and metabotropic glutamate receptor-93 
dependent long-term depression (mGluR-LTD) (Waung et al., 2008; Jakkamsetti et al., 2013; 94 
Mabb et al., 2014). Arc is also required for inverse synaptic tagging. In this process, strong 95 
neuronal stimulation induces Arc expression which binds to inactive CaMKIIβ (Okuno et al., 96 
2012). The Arc/CaMKIIβ complex then operates as a sensor to identify and induce 97 
endocytosis of AMPAR at weaker synapses thus increasing the difference between activated 98 
and non-activated synapses. Together, these findings demonstrate a pivotal role for Arc in 99 
regulating synapse strength after neuronal activation.  100 
 101 
The clathrin-mediated endocytic (CME) pathway has been the subject of intensive studies in 102 
the past decades. Therefore, the molecular machinery involved in the sequential events 103 
linking the selection of the endocytic cargo and assembly of the clathrin scaffold leading to 104 
membrane bending and scission of the newly formed clathrin-coated vesicles has been 105 
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precisely described (Saheki and De Camilli, 2012; Canagarajah et al., 2013; Kirchhausen et 106 
al., 2014). The clathrin-adaptor protein 2 (AP-2), which is a heterotetramer composed of two 107 
large (α/β2) and two small (μ2/σ2) subunits, plays an essential role in the formation of 108 
endocytic clathrin-coated vesicles (CCV). To initiate the clathrin-coat assembly the AP-2 109 
complex first binds to the transmembrane cargo that is to be internalized and subsequently 110 
binds and connects clathrin to the plasma membrane (Saheki and De Camilli, 2012; Traub 111 
and Bonifacino, 2013; Kirchhausen et al., 2014). The sequential events observed during 112 
clathrin-mediated endocytosis are conserved across different eukaryotic cell types including 113 
neurons (Saheki and De Camilli, 2012). In hippocampal neurons, the cytosolic tail of the 114 
AMPAR subunit 2 (GluA2) directly binds to AP-2 (Kastning et al., 2007) and disruption of the 115 
AMPAR/AP-2 interaction compromises the Arc-mediated facilitation of AMPAR endocytosis 116 
(Rial Verde et al., 2006). 117 
 118 
Here we show that Arc directly binds to AP-2 and that this interaction is required for Arc-119 
mediated endocytosis of GluA1 subunits and consequent changes in synaptic transmission. 120 
Under basal conditions, overexpression of Arc-wild-type (Arc-WT) reduces the amplitude 121 
and rectification of AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs), 122 
whereas Arc proteins bearing mutations in the AP-2 binding site, have little or no effect. 123 
Furthermore, depletion of AP-2 blocks the Arc-mediated reduction in mEPSC amplitude, an 124 
effect that is rescued when AP-2 expression is restored. The interaction between Arc and 125 
AP-2 is also important in homeostatic synaptic scaling, as depletion of AP-2 significantly 126 
reduces the Arc-dependent decrease in AMPAR mEPSC amplitude induced by increased 127 
neuronal activity. The discovery that the direct interaction between Arc and AP-2 facilitates 128 
rapid and sustained AMPAR endocytosis provides the mechanistic link by which constitutive 129 
endocytosis can be regulated by changes in activity in neurons. These findings further 130 
consolidate the strategic role of Arc in facilitating activity-dependent endocytosis of AMPAR 131 
in synaptic plasticity. 132 
 133 
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Materials and Methods 134 
Animals used in this study were treated in accordance with UK Animal (Scientific 135 
Procedures) Act 1986 legislation and under the appropriate national and local ethical 136 
approval. Sample size was calculated using variance from previous experiments to indicate 137 
power, with statistical significance set at 95%. Replication values are incorporated in the 138 
figures, where appropriate. 139 
 140 
Immunoprecipitation and immunoblot analysis 141 
To identify new proteins that interact with endogenous Arc/Arg3.1 proteins hippocampi from 142 
10 week-old male C57BL/6 mice were used. To extract the hippocampi, animals were deeply 143 
anaesthetized and the brains were rapidly removed and placed in ice-cold artificial CSF 144 
(aCSF) consisting of (mM): 124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4 145 
and 10 D-glucose (bubbled with 95% O2 and 5% CO2). Hippocampi were then isolated from 146 
the surrounding tissue and cut into small pieces using a dissecting microscope (Leica LED 147 
1000). The tissue was then homogenized in Eppendorf Scientific tubes with a pellet pestle in 148 
ice-cold solution composed of: 10 mM HEPES, 0.32 M sucrose and protease inhibitor 149 
cocktail (Roche) and rotated for 1 h at 4°C. Homogenate was centrifuged at 13,000 g for 15 150 
min, the supernatant collected and protein levels determined (BCA protein assay kit, Thermo 151 
Scientific). 500 µg of protein making 500 µl of final volume was incubated with 1 µg of rabbit 152 
polyclonal anti-Arc antibody (Synaptic Systems, 156-003) and 15 µl of pre-washed protein G 153 
agarose beads (Upstate-Millipore, 16-266) and rotated for 3 h at 4°C. As a negative control, 154 
500 µg of protein was incubated with 15 µl with protein G agarose beads only. Arc-IP and 155 
negative control samples were centrifuged at 7000 g for 30 sec to precipitate the beads. The 156 
supernatant was removed and the beads washed 3 times with lysis buffer containing 1 mM 157 
EDTA, 1 M Tris-HCl (pH 7.5), 1% Triton X-100, 1 mM Sodium Orthovanadate, 50 mM 158 
Sodium Fluoride, Sodium pyrophosphate, 0.27 M Sucrose, 20% NaN3 and protease inhibitor 159 
cocktail (Roche). Proteins were eluted from the beads with 20 µl of 5X loading buffer, and 160 
 7 
 
the total amount of the eluted protein from the beads were loaded into a 10% SDS-PAGE 161 
gels and separated for 1.5 cm using electrophoresis system.  162 
To further confirm the endogenous interaction between Arc and AP-2 in the hippocampus, 163 
we used the co-IPs experimental conditions described above. Eluted IP proteins as well as 164 
inputs were separated in 10% SDS-PAGE gels, transferred into membrane using 165 
electrophoresis system and blots were incubated overnight with primary antibodies: rabbit 166 
anti-Arc/Arg3.1 (1:1000 dilution), mouse anti-α-adaptin1/2 (1:1000 dilution, sc-17771) and 167 
goat anti-clathrin HC (1:1000 dilution, sc-6579). Normal Rabbit IgG (1:1000; RD Systems, 168 
AB-105-C) was used as negative control for the IP experiments. Appropriate secondary 169 
antibodies were used to detect proteins levels.  170 
 171 
Proteomics and MS analysis 172 
Each gel lane (Arc IP and control) were cut in small pieces and subjected to in-gel tryptic 173 
digestion using a ProGest automated digestion unit (Digilab UK). The resulting peptides 174 
were fractionated using a Dionex Ultimate 3000 nanoHPLC system. Briefly, peptides in 1% 175 
(v/v) formic acid were injected onto an Acclaim PepMap C18 nano-trap column (Dionex). 176 
After washing with 0.5% (v/v) acetonitrile 0.1% (v/v) formic acid peptides were resolved on a 177 
250 mm × 75 μm Acclaim PepMap C18 reverse phase analytical column (Dionex) over a 178 
120 min organic gradient with a flow rate of 300 nl min−1. Peptides were ionized by nano-179 
electrospray ionization at 2.3 kV using a stainless steel emitter with an internal diameter of 180 
30 μm (Proxeon). Tandem mass spectrometry analysis was carried out on a LTQ-Orbitrap 181 
Velos mass spectrometer (Thermo Scientific). The Orbitrap was set to analyze the survey 182 
scans at 60,000 resolution and the top twenty ions in each duty cycle selected for MS/MS in 183 
the LTQ linear ion trap. Data was acquired using the Xcalibar v2.1 software (Thermo 184 
Scientific). The raw data files were processed and quantified using Proteome Discoverer 185 
software v1.2 (Thermo Scientific) with searches performed against the UniProt rat database 186 
by using the SEQUEST algorithm with the following criteria; peptide tolerance = 10 ppm, 187 
trypsin as the enzyme, carbamidomethylation of cysteine as a fixed modification and 188 
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oxidation of methionine as a variable modification. The reverse database search option was 189 
enabled and all data was filtered to satisfy false discovery rate (FDR) of less than 5%. Only 190 
hits from the Arc-co-IPs were considered for further characterization. The proteomics 191 
experiments were repeated twice  192 
 193 
Hippocampal cell culture and transfection  194 
Hippocampal neuronal cultures were prepared from either male or female postnatal day 0 195 
pups from C57BL/6 wild-type mice as described previously (Canal et al., 2011). Briefly, 196 
hippocampi were extracted from the brain at 4°C, subject to digestion with trypsin (Sigma-197 
Aldrich) and mechanically dissociated with DNAse (Sigma-Aldrich). Cells were plated onto 198 
22-mm glass coverslips coated with poly-L-lysine hydrobromide (0.5mg/ml, Sigma-Aldrich). 199 
The plating medium consisted of Neurobasal-A medium (Gibco) supplemented with 200 
Gentamycin (ForMedium), L-Glutamine (ForMedium), 2% B27 (Gibco) and 5% horse serum 201 
(Gibco). The following day, the plating medium was changed for horse serum free feeding 202 
medium. Cultures were maintained at 37°C and 5% CO2 in a humidified incubator. For 203 
immunocytochemistry and patch-clamp recordings, hippocampal cultured neurons were 204 
used at 14-16 days in vitro (DIV) and transfection were performed using Lipofectamine 2000 205 
(Life technologies). For the patch-clamp recordings cells expressing Arc cDNAs were used 206 
15-22 h after transfection and cells expressing shRNAs were transfected at 6-7 DIV and 207 
recorded at 14-16 DIV.  208 
 209 
Cell lineages culture and transfection 210 
Human neuroglioma 4 (H4) cells obtained from the American Type Culture Collection 211 
(Manassas, VA) were cultured in Dulbecco’s modified Eagle medium (DMEM; Life 212 
technologies), supplemented with 100 U of penicillin/ml, 0.1 mg of streptomycin/ml and 10% 213 
(vol/vol) fetal bovine serum (FBS) and transiently transfected using Lipofectamine 2000 (Life 214 
technologies). Neuroblastoma x Spinal Cord (NSC) hybrid mouse cell lines (Cashman et al., 215 
1992) cultured in supplemented DMEM were transfect with nc shRNA, µ2-shRNA2, µ2-216 
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shRNA3 constructs using calcium phosphate as previously described (Canal et al., 2011). 217 
After 72-96 h of transfection, cells were washed, lysed in the presence of protease inhibitor 218 
cocktail (Roche) and 10 µg of protein were loaded onto a 10% acrylamide gel. Proteins were 219 
separated using a SDS-PAGE electrophoresis system and transferred onto Hydrobond-ECL 220 
membrane (GE healthcare). Membranes were incubated overnight with primary specific 221 
mouse anti-AP-50 µ2 subunit antibody (1:500 dilution; BD 610350), and GAPDH (1:1000 222 
dilution; Abcam ab8245 for Figure 6) or affinity purified rabbit polyclonal anti-GAPDH 223 
antibody (1:1000 dilution; Sigma Aldrich G9545, for Figure 3). The membranes were 224 
incubated with appropriate HRP-linked secondary antibodies anti-Mouse IgG (Cell Signaling 225 
7076), anti-Mouse IgG (NA931V GE Healthcare) or anti-rabbit IgG (NA934V GE Healthcare) 226 
incubated for 1 h at room temperature and blots developed using ECL reagents.  227 
 228 
Recombinant DNA Constructs 229 
Full-length mouse Arc cDNA (NM_018790.3) in pCMV-SPORT7 vector was purchased from 230 
Open Biosystems (Huntsville, AL) and used as a template to generate the Arc constructs. 231 
The pGFP-Arc plasmid was generated by cloning the Arc full length sequence as an 232 
EcoRI/SalI fragment into the pEGFP-C2 vector (Clontech). Site-directed mutagenesis 233 
(QuickChange II kit Qiagen) was used to mutate the tryptophan 197 to alanine in the 234 
pEGFP-Arc(WT) construct. To generate constructs encoding Arc195-199A, a synthetic cDNA 235 
sequence was obtained from GenScript (Piscataway, NJ), encoding the mouse Arc residues 236 
1 to 700, in which codons to residues 195 to 199 (residues QSWGP) of the original Arc 237 
sequence were replaced by codons to alanine (QSWGP/AAAAA). The Arc195-199A mutant 238 
sequence was then used to replace the corresponding sequence in pGFP-ArcWT, using 239 
EcoRI and a naturally occurring BglII (nt 647-652) restriction sites. This generated the pGFP-240 
Arc(W197A) and the pGFP-Arc(195-199A) plasmids, respectively. The plasmids encoding untagged 241 
Arc and Arc fused to mCherry (WT and mutants) were obtained by inserting the Arc cDNAs 242 
from pEGFP plasmids as EcoRI/SalI fragments into the pCIneo (Promega) or the pmCherry-243 
C2 vectors (Clontech), respectively. To express Arc and Arc mutants in E. coli the full-length 244 
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Arc (WT), Arc 1-194 and Arc 1-199 sequences were amplified by PCR with specific primers 245 
and cloned into the pET28a vector using EcoRI and SalI restriction sites. The resulting 246 
plasmids encode Arc fused to a hexahistidine tag at the N-terminus. To express GST-Arc(WT)’ 247 
GST-Arc(195-199A) and GST-Arc(W197A) fusion proteins in E. coli, the Arc-WT coding sequences 248 
in pEGFP-C2 were subcloned into pGEX5.1 (GE Healthcare) as EcoRI/SalI inserts. The 249 
pcDNA3.1-µ2-mCherry vector was used to express µ2-adaptin in rescue experiments. This 250 
construct was generated using a two-step cloning strategy. Firstly, cDNA encoding mouse 251 
µ2 was amplified from pGADT7-µ2 (Guo et al., 2013) and used to replace the Leucine 252 
Zipper (LZ) sequence, in a pcDNA3.1-based plasmid consisting of a LZ sequence followed 253 
by a linker and the C-terminal (VC: 159-239) fragment of Venus YFP, provided by Dr 254 
Stephen Michnick (MacDonald et al., 2006). This construct was subsequently used to 255 
replace the VC sequence by the mCherry sequence, thus generating pcDNA3.1-µ2-256 
mCherry. To obtain the GFP-tagged Dynamin2 (WT) construct the open reading frame of 257 
dynamin 2 was cloned into pEGFP-N1 as a HindIII and EcoRI insert. The pEGFP-C3 based 258 
plasmid encoding GFP-Triad3A was previously described (Mabb et al., 2014). All open 259 
reading frames were verified by nucleotide sequence analysis. 260 
Recombinant protein expression and GST-pull-down assays 261 
The four subunits of rat AP-2 complex comprising residues 1 to 621 from αC adaptin (α-262 
trunk) fused to glutathione-S-transferase (GST) at the N-terminus, residues 1 to 591 from β2 263 
adaptin fused to a hexahistidine tag at the C-terminus, and the full length μ2 and σ2 adaptin; 264 
(hereafter referred to as AP2 core) were co-expressed in E. coli BL21 Rosetta (DE3) cells 265 
from a pST39 vector (Sheffield et al., 1999) under the control of T7 promoter with each gene 266 
having its own ribosome-binding site (Chaudhuri et al., 2007; Chaudhuri et al., 2009). For 267 
GST-AP-2 core expression, bacteria were grown at 37˚C to an optical density at 600 nm of 268 
0.8. Then cultures were shifted to 18˚C and the expression was induced with 0.2 mM IPTG 269 
(isopropyl-β-D-thiogalactopyranoside) for 12 hours. The cell pellet was re-suspended in ice-270 
cold lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 10% glycerol, 2 mM EDTA, 10 mM 271 
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DTT), supplemented with 500 µg/ml lysozyme and 1 mM 4-(2-Aminoethyl) benzenesulfonyl 272 
fluoride hydrochloride (AEBSF) and disrupted by sonication. Insoluble material was removed 273 
by centrifugation and the AP-2 core in the supernatant was purified using a His-trap column 274 
(GE Healthcare). Briefly, the AP-2 core complex was bound to the His-trap column via the 275 
6xHis-β2 subunit, repeatedly washed with Tris-buffer solution (TBS) composed of 50 mM 276 
Tris-HCl [pH 7.4], 500 mM NaCl supplemented with 30 mM of imidazol (Sigma) and eluted 277 
with TBS with 0.25 M of imidazol. Recombinant GST (pGEX plasmid), GST-Arc(WT), GST-278 
Arc(195-199A), GST-Arc(W197A) and 6XHis-Arc (wild-type and truncated) were also expressed in 279 
E. coli BL21 Rosetta (DE3) cells at 30˚C with 0.5 mM IPTG. The pellet was re-suspended in 280 
ice-cold lysis buffer, sonicated and after centrifugation, supernatant containing the soluble 281 
proteins was used for pull-down assays.  282 
Recombinant GST-AP-2 core or GST alone was immobilized onto glutathione-sepharose 283 
beads (GE Healthcare) overnight at 4˚C. Beads were washed with ice-cold TBS containing 284 
5% of Triton X-100 (Sigma) and incubated with either His-trap column purified 6xHis-Arc or 285 
total cell lysates of E. coli expressing 6x-His-Arc proteins for three hours. After four washes 286 
with ice-cold TBS plus 5% of Triton X-100 the beads were re-suspended in sample buffer 287 
(SDS 4%, Tris-HCl 160 mM [pH 6.8], glycerol 20%, DTT 100 mM and bromphenol blue 288 
0.005%), boiled and proteins were separated by SDS-PAGE and transferred onto a 289 
nitrocellulose membrane (GE Healthcare), which were then blocked for one hour with PBS, 290 
0.1% tween 20 and 5% milk powder. Primary mouse monoclonal anti-His tag antibody 291 
(1:1000 dilution, Sigma H1029) were added in PBS, 1% BSA for one hour. After three 292 
washes with PBS-T, the membranes were incubated with HRP-conjugated secondary 293 
antibody for 1 h and washed again.  294 
Recombinant GST, GST-Arc(WT), GST-Arc(W197A) and GST-Arc(195-199A) were immobilized onto 295 
glutathione-sepharose beads overnight at 4˚C. Beads were incubated with either total brain 296 
tissue lysate, obtained as described earlier for hippocampi lysate, or total lysates of HEK293 297 
cells expressing either dynamin 2-GFP or GFP-Triad3A for 1 h at 4 °C on ice. The beads 298 
were centrifuged at 100 × g, washed three times with lysis buffer, supplemented with 1% 299 
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(v/v) Triton X-100, and subsequently resuspended in SDS-PAGE sample buffer. Beads were 300 
boiled, and proteins were resolved by SDS-PAGE and analyzed by immunoblot as described 301 
above using mouse monoclonal anti-AP-50 µ2 subunit (1:500 dilution; BD 611350) ), anti-α-302 
adaptin1/2 (1:1000 dilution, sc-17771) and rabbit polyclonal anti-GFP antibodies. Proteins 303 
were detected using ECL reagents. 304 
Immunocytochemistry 305 
H4 neuroglioma cells (ATCC) were transfected with plasmids encoding a myc-tag at the N-306 
terminus of GluA1 (Leuschner and Hoch, 1999) together with plasmids encoding either 307 
mCherry, mCherry-Arc-WT or mCherry-Arc(W197A). 20 h after transfection, cells were fixed 308 
using 4% paraformaldehyde (PFA, pH 7.4) in 0.1 M phosphate-buffered saline (PBS) for 15 309 
min at room temperature and incubated for 30 min at 37°C in blocking solution (0.2% pork 310 
skin gelatin) in PBS. Cells were then incubated with hybridoma culture supernatant (9E10) 311 
containing mouse monoclonal anti-myc antibody (at 1:10 dilution). Cells were washed with 312 
PBS and incubated with Alexa Fluor 488 anti-mouse IgG (1:1000; Life technologies) diluted 313 
in blocking solution. Cells were then permeabilized for 10 min with 0.1% Triton X-100 in PBS 314 
and incubated again with rabbit polyclonal anti-myc antibody (a gift from R Hegde, MRC, 315 
LMB, Cambridge, UK) for 30 min at 37°C in blocking solution. This was followed by 316 
incubation with Alexa Fluor 647 anti-rabbit IgG (1:1000; Life technologies) diluted in blocking 317 
solution. Coverslips were mounted on glass slides, and cells were imaged using a confocal 318 
laser-scanning microscope (LSM) using a Zeiss LSM 780 confocal microscope (Zeiss, Jena, 319 
Germany).  320 
 321 
Biotinylation assays 322 
To analyze the amount of surface and intracellular GluA1 and GluA2 proteins H4 323 
neuroglioma cells were transfected and subject to a biotinylation protocol previously 324 
described (Eales et al., 2014). Briefly, the same amount of H4 cells were seeded in each 325 
well of six wells dishes (3x105 cells/well) and then transfected with 2 μg of plasmids encoding 326 
 13 
 
N-terminus-myc-tagged GluA1 or GluA2 (Leuschner and Hoch, 1999) in combination with 2 327 
μg of pCIneo, pCIneo-Arc(WT) or pCIneo-Arc(W197A) using lipofectamine 2000. After 24 hours 328 
the cells were washed and incubated with 1 ml of 0.25 mg/mL of EZ-Link Sulfo-NHS-SS-329 
Biotin (Thermo Scientific) in ice-cold PBS for 15 min at 4 °C. The cells were washed twice 330 
with ice cold PBS, with 3 mL of NH4Cl 50 mM for 5 minutes (4°C on a shaker) and then 331 
once more with PBS. After washing, cells were lysed with 100 µl of lysis buffer (described 332 
above) containing protease inhibitors, rotated for 1 hour at 4°C, centrifuged at 20.000 g for 333 
10 minutes at 4°C and the supernatants collected. The protein concentration was assayed 334 
using the BioRad Protein Assay Reagent and equal amounts were incubated with pre-335 
washed 30 ul of NeutrAvidin® Ultra-link Resin (Life Technologies) for 3 hours on a wheel at 336 
4°C. The beads were washed 3 times with lysis buffer, and the proteins eluted from the 337 
beads using 20 µl of 5x loading buffer. Proteins were loaded on an 8% SDS-PAGE gel. The 338 
input represents 1% of the total protein incubated with the beads. The Western blot was 339 
performed as described above.  340 
Lentiviruses production  341 
A lentiviral transduction system was used to achieve efficient delivery of specific microRNA-342 
adapted shRNA sequences into neurons. Double-stranded oligonucleotides encoding 343 
shRNAs targeting the mouse µ2 subunit (shRNA1: 344 
tgctgtgaattgccctccatatggttgttttggccactgactgacaaccatatagggcaattca/ 345 
cctgtgaattgccctatatggttgtcagtcagtggccaaaacaaccatatggagggcaattcac; shRNA2: 346 
tgctgcatattggtactctattgcctgttttggccactgactgacaggcaatagtaccaatatg/ 347 
cctgcatattggtagtattgcctgtcagtcagtggccaaaacaggcaatagagtaccaatatgc; shRNA3: 348 
tgctgatctgcaggacattgcttcacgttttggccactgactgacgtgaagcagtcctgcagat/ 349 
cctgatagattcctatcaggctggtcagtcagtggccaaaaccagcctgagttaggaatctatc) were cloned into the 350 
linearized pcDNA6.2-GW/EmGFP-miR vector (Invitrogen). The sequences were designed 351 
using the “BLOCK-iT™ RNAi Designer” software from Invitrogen to identify sequences 352 
specific for mouse µ2 that are not predicted to knock down expression of any other genes. In 353 
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addition, the sequences have 100% homology to the target sequence and result in target 354 
cleavage. The vector contains flanking sequences allowing the shRNAs to be expressed and 355 
processed analogous to endogenous shRNAs. This arrangement enables the expression of 356 
the shRNA cassette from an RNA polymerase II promoter. In addition, emGFP is expressed 357 
iso-cistronically from the same promoter to allow the precise identification of the transduced 358 
cells. As a negative control, the plasmid pcDNA6.2-GW/EmGFP-miR-neg control (Invitrogen) 359 
was used. This plasmid contains an insert that forms a hairpin structure which is processed 360 
into mature shRNA, but is predicted not to target any known vertebrate gene 361 
(gaaatgtactgcgcgtggagacgttttggccactgactgacgtctccacgcagtacattt). The above expression 362 
cassettes were transferred into the lentiviral expression vector pLenti6/V5-DEST (Invitrogen) 363 
by gateway cloning. Lentiviruses were produced according to the instructions of the 364 
manufacturer (Invitrogen; Block-It HiPerform Lentiviral Pol II RNAi Expression system with 365 
emGFP; K4934). Lentivirus particles were collected from the culture supernatants, purified 366 
and concentrated by incubation with 8.5% PEG 6000 and 0.4M NaCl for 1.5 hours at 4°C, 367 
followed by centrifugation at 7000 g for 10 min (4°C). Pellets were re-dissolved in 368 
neurobasal medium. 369 
 370 
Bicuculline incubation 371 
To induce a chronic increase in neuronal activity, hippocampal cultures were incubated with 372 
bicuculline (40 µM, Sigma Aldrich) for 48 h prior to experimental work. 373 
 374 
Electrophysiological recordings and analysis of AMPAR-mediated miniature excitatory 375 
postsynaptic currents (mEPSCs) 376 
Miniature excitatory postsynaptic currents (mEPSCs) were recorded from 15-18 DIV cultured 377 
pyramidal hippocampal neurons (Mabb et al., 2014). A coverslip was transferred to the 378 
recording chamber and perfused at a constant flow rate of (2-3 min-1) with a recording 379 
solution composed of (mM): 127 NaCl, 1.9 KCl, 1 MgCl2, 2 CaCl2, 1.3 KH2PO4 , 26 NaHCO3, 380 
10 D-glucose, pH 7.4 (when bubbled with 95% O2 and 5% CO2 , 300 mOSM) at 28-30ºC. To 381 
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isolate AMPA receptor mediated mEPSCs, tetrodotoxin (1 µM, Tocris), picrotoxin (50 µM, 382 
Sigma-Aldrich) and L-689,560 (5 µM, Tocris) were present in the recording solution. 383 
Cultured neurons were visualized using IR-DIC optics with an Olympus BX51W1 microscope 384 
and Hitachi CCD camera (Scientifica, Bedford UK). Whole-cell patch clamp recordings were 385 
made from transfected (identified by fluorescence at 488 nm) and neighboring untransfected 386 
pyramidal neurons with patch pipettes (5-8 MΩ) made from thick walled borosilicate glass 387 
(Harvard Apparatus, Edenbridge UK) filled with (mM): potassium gluconate 135, NaCl 7, 388 
HEPES 10, EGTA 0.5, phosphocreatine 10, MgATP 2, NaGTP, pH 7.2, 290 mOSM). 389 
Recordings of mEPSCs were obtained at a holding potential of -75 mV using an Axon 390 
Multiclamp 700B amplifier (Molecular Devices, USA), filtered at 3 kHz and digitized at 20 391 
kHz (Digidata 1440A, Molecular Devices). For rectification experiments, the intracellular 392 
solution contained (mM): CsCl 135, HEPES 10, EGTA 10, Mg-ATP 2, spermine 0.1; pH 7.2 393 
with tetraethylammonium-0H (TEA-OH); 285 mOSM. To calculate the rectification index, 394 
mEPSC recordings were made at holding potentials of -60 mV and +40 mV. Data acquisition 395 
was performed using pClamp 10 (Molecular Devices). 396 
Analysis of mEPSCs was performed using MiniAnalysis software (SynaptoSoft, Decatur, 397 
GA). For most experiments, where the holding potential was -75 mV, events were manually 398 
analyzed and were accepted if they had an amplitude >6 pA and a faster rise than decay. 399 
For the rectification experiments, where the holding potential was -60 and +40 mV and thus 400 
mEPSCs had a smaller amplitude, events were accepted if they had an amplitude > 3 pA 401 
and a waveform with a faster rise than decay. Cumulative probability curves for mEPSC 402 
amplitude were constructed from 1000-2000 mEPSCs pooled from all recordings, with the 403 
same number of mEPSCs (150) measured from each recording (Origin, Microcal). The 404 
interval between events was measured using MiniAnalysis software. To measure mEPSC 405 
kinetics, mEPSCs within individual recordings were aligned on the half-amplitude of their rise 406 
and averaged (50-100 mEPSCs were averaged in each recording). The decay of the mean 407 
current from each recording was fitted with a single exponential (maximum likelihood, 408 
MiniAnalysis or Microcal Origin). Rise times were measured from mean currents as the time 409 
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required for the current to rise from 10 to 90 % of peak amplitude. The rectification index was 410 
calculated for each recording (peak amplitude at +40 mV divided by peak amplitude at -60 411 
mV) and then the mean rectification index was calculated for each experimental connection. 412 
For each cell an average of 100-200 mEPSCs were analyzed. Individual mEPSCs were 413 
aligned to 50 % of the rise, averaged and then the mean amplitude was measured from the 414 
peak of this mEPSC waveform. Statistical significance was measured using the Mann-415 
Whitney test. Where possible, comparisons were made between transfected and 416 
untransfected neighboring neurons in the same culture. For each experimental condition 417 
cells were recorded and analyzed using hippocampal cultures from 4-5 different 418 
preparations. 419 
 420 
Statistical Analysis  421 
Data was analyzed using Prism (Version 5.04, GraphPad) and Statistical Package for the 422 
Social Sciences 21 (IBM) software. Mann-Whitney t-tests, Kolmogorov-Smirnov test, one-423 
way ANOVA and the corresponding post-hoc tests (Tukey or Dunn’s) were performed as 424 
appropriate. 425 
 426 
Results 427 
Arc interacts with the AP-2 complex in neurons 428 
Arc has been shown to regulate glutamatergic synaptic transmission by dynamically 429 
enhancing AMPAR endocytosis in postsynaptic neurons (Shepherd et al., 2006; Mabb et al., 430 
2014). Given the importance of Arc in facilitating AMPAR endocytosis during synaptic 431 
transmission we speculated that it may play a decisive role in selecting the cargo to be 432 
internalized. To test whether Arc interacts with proteins of the clathrin-mediated endocytic 433 
(CME) machinery and whether Arc is involved in selecting the cargo to be targeted for 434 
endocytosis, we used the specific rabbit anti-Arc antibody to immunoprecipitate (IP) 435 
endogenous Arc from adult C57BL6/J mice hippocampal lysate combined with mass 436 
spectrometric analysis to identify novel Arc binding partners. The control for the IP was 437 
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obtained by incubating hippocampal lysate protein with the G-agarose beads in the absence 438 
of Arc antibody. The eluted proteins from both Arc-IP and control-IP samples were subjected 439 
to tandem mass spectrometry analysis. We only considered peptides present in the Arc-IPs 440 
for further analysis and discarded unspecific peptides present in both Arc- and control-IPs. 441 
Using this criteria we identified different subunits of the adaptor protein complex-2 (AP-2) as 442 
endogenous binding partners of Arc, including the two α adaptin isoforms: α also known as 443 
αA (19 peptides and recovery of 22.83%; NP_031484) and α2, also known as αC (11 444 
peptides and recovery of 12.37%; NP_031485) as well as β2 (11 peptides and recovery of 445 
12.38%; NP_082191) and μ2 (9 peptides and recovery of 20.79%; Q3TWV4). These 446 
peptides were found independently in two experimental repeats. We also found clathrin 447 
heavy chain (30 peptides and recovery of 20%; NP_001003908), dynamin 1 (10 peptides 448 
and recovery of 10.57%; NP_034195), CamKII β subunit (9 peptides and recovery of 449 
20.48%, NP_031621) and PSD95 (2 peptides and recovery 5.77%, NP_031890). 450 
Importantly, PSD95, dynamin and CamKIIβ have previously been shown to co-IP with Arc 451 
(Lyford et al., 1995; Chowdhury et al., 2006; Okuno et al., 2012). To further confirm that Arc 452 
interacts with AP-2 endogenously, we immunoprecipitated Arc protein from hippocampal 453 
lysate as previously described and resolved the proteins using SDS-PAGE. Immunoblot 454 
analysis confirmed that Arc co-immunoprecipitates with the α subunit of the AP-2 complex 455 
(Fig. 1a,b). We observed that clathrin heavy chain also co-immunoprecipitates with Arc (Fig. 456 
1b). This result was expected as clathrin heavy chain is known to interact with AP-2 (ter 457 
Haar et al., 2000; Edeling et al., 2006; Knuehl et al., 2006). Together these findings suggest 458 
an interaction between Arc and the proteins of the CME machinery that are responsible for 459 
selecting the cargo to be internalized. To test whether Arc directly interacts with AP-2, we 460 
performed in vitro GST-pull-down assays using recombinant forms of Arc-wild-type (Arc-WT) 461 
and AP-2. Previous studies used recombinant AP-2 “core” complexes to demonstrate the 462 
direct interaction between AP-2 and the cytosolic tail of transmembrane cargo proteins 463 
(Höning et al., 2005) or the HIV-1 accessory protein, Nef (Chaudhuri et al., 2007; Lindwasser 464 
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et al., 2008; Chaudhuri et al., 2009). Therefore, we produced recombinant Arc-WT fused to a 465 
hexahistidine tag and recombinant GST-tagged AP-2 core, comprising the N-terminal “trunk” 466 
domains of α and β2 subunits, plus the full-length μ2 and σ2 subunits in E. coli. The 467 
recombinant AP-2 core complex and Arc proteins were affinity purified (Fig. 1c) and used to 468 
show that GST-tagged AP-2 core binds mouse Arc-WT, as detected by immunoblot analysis 469 
(Fig. 1d). We then used the same GST-pull-down approach to map the region of Arc that 470 
interacts with AP-2. Our initial experiments demonstrated that a C-terminal fragment of Arc 471 
comprising residues 155 to 396 is sufficient to mediate the interaction with AP-2. We then 472 
tested whether Arc mutants bearing cumulative C-terminal deletions of 40 amino acid 473 
residues would retain the capacity to bind AP-2. Using this approach we showed that the Arc 474 
C-terminus (residues 200-396, Fig. 1e) is not essential for the Arc-AP-2 interaction, as 475 
truncated Arc missing these residues (Arc1-199) was still able to interact with AP-2 (Fig. 1f). 476 
Interestingly, deletion of a further five amino acid residues from the C-terminus of Arc (Arc1-477 
194) was sufficient to prevent AP-2 binding (Fig. 1g). Binding of Arc recombinants to GST 478 
alone was negligible, thus confirming the specificity of the Arc/AP-2 interactions (Fig. 1d,f,g). 479 
Together these results demonstrated a direct and specific interaction of Arc with the fully 480 
assembled AP-2 core complex.  481 
 482 
Conservative tryptophan 197 mediates the Arc/AP-2 interaction 483 
Our GST-pull-down experiments indicate that the Arc 195QSWGP199 amino-acid sequence is 484 
required for its interaction with AP-2. Therefore, we reasoned that a single substitution of the 485 
highly conserved tryptophan in position 197, may compromise the Arc/AP-2 interaction. To 486 
test this, we performed in vitro protein binding experiments using immobilized recombinant 487 
GST-Arc(WT), GST-Arc(195-199A) or GST-Arc(W197A) fusion proteins to pull-down the endogenous 488 
α or μ2 subunit of AP-2 from total brain tissue lysates. We detected a robust interaction 489 
between GST-Arc(WT) and μ2 (Fig. 2a). However this interaction was dramatically reduced 490 
when GST-Arc(W197A), Arc(195-199A) or GST alone were used as bait (Fig. 2a), indicating that 491 
W197 is crucially involved in the interaction with AP-2. It was previously shown that Arc 492 
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interacts with dynamin-2 and that an internal deletion of 195-214 aa in Arc disrupt this 493 
interaction (Chowdhury et al., 2006). To test the capacity of Arc(W197A) to interact with 494 
dynamin, we performed similar in in vitro binding analyses using immobilized GST-Arc(WT) or 495 
GST-Arc(W197A) to pull-down GFP-dynamin-2 from HEK293 cell lysates. We confirmed that 496 
Arc(WT) binds to dynamin, however there is a significant reduction in the interaction between 497 
Arc(W197A) mutant and dynamin (Fig. 2b). In contrast, the Arc mutants carrying alanine 498 
substitutions in the AP-2 binding motif still interact with the RING domain of the ubiquitin 499 
ligase Triad3A/RNF216 (Fig. 2c), a protein recently described to interact with Arc (Mabb et 500 
al., 2014). Binding of Arc(W197A) and Arc(195-199A) to Triad3A indicates that these alanine 501 
mutations do not cause gross conformational changes in Arc which could prevent protein-502 
protein interaction. 503 
 504 
Arc-mediated internalization of GluA1 requires the Arc/AP-2 interaction  505 
Arc(WT) overexpression in hippocampal neurons reduces surface levels of AMPAR by 506 
selectively enhancing endocytosis. We reasoned that Arc-mediated endocytosis of AMPAR 507 
may be linked to its ability to interact with the endocytic adaptor AP-2. To test this, we co-508 
expressed myc-GluA1 with either Arc(WT) or the Arc(W197A) mutant in H4 human neuroglioma 509 
cells, and performed biotinylation assay to monitor GluA1 and GluA2 surface expression 510 
levels. As previously shown in hippocampal neurons (Chowdhury et al., 2006), 511 
overexpression of Arc-WT in H4 cells resulted in a significant reduction of myc-GluA1 512 
surface expression levels (Fig. 3a). Importantly, the reduction in myc-GluA1 surface 513 
expression was blocked when Arc(W197A) mutant, that does not bind AP-2, was co-expressed 514 
with myc-GluA1 (Fig. 3a). Interestingly no changes in GluA2 surface expression were 515 
observed when myc-GluA2 construct was co-expressed with either Arc(WT) or the Arc(W197A) 516 
mutant (Fig. 3b), indicating that the GluA2 subunit is potentially less sensitive to Arc than 517 
GluA1 as previously suggested by Chowdhury et al. (2006). To test whether Arc 518 
overexpression induces general endocytosis of AP-2/clathrin cargo proteins, we examined 519 
the surface levels of EGF receptor (EGFR) in H4 cells expressing either Arc-WT or the 520 
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Arc(W197A) mutant. As expected, expression of Arc has no significant effect in surface 521 
expression of EGFR (Fig. 3b). To confirm whether Arc(W197A) mutant had an impact on the 522 
Arc-dependent internalization of GluA1, we used the same experimental condition described 523 
above to perform immunocytochemistry to label the amount of n terminus-myc-tagged GluA1 524 
expressed at the surface. Confocal microscopy analyses confirmed that Arc(WT) 525 
overexpression promotes a significant reduction of the GluA1 expression at the cell surface, 526 
an effect that is impaired in cells expressing the Arc(W197A), that cannot bind to AP-2 (Fig. 3c-527 
g). Together, these results indicate that Arc/AP-2 interaction is required to facilitate AMPAR 528 
internalization. 529 
 530 
The Arc/AP-2 interaction regulates AMPAR-mediated synaptic currents  531 
Previous findings have demonstrated that under basal conditions hippocampal cultured 532 
neurons overexpressing Arc-WT have significantly less AMPAR on their surface than 533 
neighboring untransfected neurons (Shepherd et al., 2006). There is also a significant 534 
reduction in the amplitude of AMPAR-mediated synaptic currents in CA1 neurons 535 
overexpressing Arc-WT protein in hippocampal slices (Rial Verde et al., 2006). Conversely, 536 
cultured hippocampal neurons from Arc knockout mice exhibit an increased density of 537 
AMPAR at the cell surface and a deficit in AMPAR endocytosis (Chowdhury et al., 2006). 538 
Since Arc facilitates endocytosis of AMPAR and we have demonstrated that Arc directly 539 
binds to the AP-2 complex, we predicted that the Arc/AP-2 interaction regulates expression 540 
of synaptic AMPAR. To test our prediction, we first recorded AMPAR-mediated mEPSCs 541 
from cultured hippocampal neurons overexpressing an Arc-WT-GFP-tagged construct and 542 
from untransfected neighboring cells in the same cultures. This approach was used to 543 
negate any variations in AMPAR expression which may arise from differences in cell density. 544 
Recordings from cells expressing EGFP alone were used as a control for transfection. In 545 
agreement with previous studies, a significant decrease in mEPSC amplitude was observed 546 
in cells over-expressing Arc(WT) compared to untransfected neighboring cells (Fig. 4a(i)); Rial 547 
Verde et al., 2006; Shepherd et al., 2006). Examination of the amplitude probability curves 548 
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from Fig. 4a shows that the majority of AMPAR-mediated mEPSCs had smaller amplitudes 549 
in the cell where Arc(WT) was overexpressed (peak shifted to the left, red trace) compared to 550 
the untransfected neighboring cell (black trace). In contrast, there was no significant 551 
difference in the amplitude of mEPSCs recorded in an eGFP-expressing cell and its 552 
untransfected neighbor (Fig. 4b(i)).  553 
To test whether the Arc-mediated reduction in the AMPAR mEPSC amplitude is dependent 554 
on an interaction with AP-2, we recorded mEPSCs from hippocampal cultures 555 
overexpressing either Arc(195-199A)- or Arc(W197A)- GFP-tagged mutant constructs. As predicted, 556 
the reduction in AMPAR-dependent mEPSC amplitudes observed in cells overexpressing 557 
Arc(W197A) or Arc(195-199A) was significantly less pronounced when compared to cells 558 
overexpressing Arc(WT) (Fig. 4c,d(i)).Pooled data is displayed as cumulative probability 559 
distributions (Fig. 4e) and as bar charts plotting the mean amplitude and interval (Fig. 4f-g).  560 
Our biochemical data shows that Arc preferentially internalises GluA1 rather than GluA2 561 
subunits (Fig. 3a-b). To test whether Arc has similar effects on the endogenous AMPA 562 
receptors, which are expressed at synapses, we measured the rectification of AMPA 563 
receptor mediated mEPSC amplitudes. The reduction in the surface expression of synaptic 564 
AMPA receptors containing GluA1 subunits would be expected to reduce rectification at 565 
positive holding potentials (Bowie and Mayer, 1995; Kamboj et al., 1995; Plant et al., 2006). 566 
As predicted, the rectification index (calculated by dividing the amplitude of mEPSCs at +40 567 
mV by the amplitude at -60 mV) was significantly increased in cells expressing Arc(WT) when 568 
compared to GFP and ArcW197A expressing cells (Fig. 4h-i). Neither mEPSC rise or decay 569 
kinetics were significantly effected by overexpression of Arc(WT), Arc mutants or eGFP (Fig. 570 
5a-d). The consistency in mEPSC rise and decay kinetics across recordings (Fig. 5c-d) 571 
demonstrates that any changes in mEPSC amplitude are a result of receptor internalisation 572 
rather than variations in recording quality. These experiments suggest that the reduction in 573 
mEPSC amplitude induced by Arc(WT) overexpression in hippocampal neurons is dependent 574 
on the binding of Arc(WT) to the AP-2 complex. 575 
 576 
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The AP2 subunit μ2 is required for the Arc(WT)-induced reduction in mEPSC amplitude 577 
Previous studies have shown that depletion of the µ2 subunit compromises the stability of 578 
the remaining subunits of AP-2 and also that the complexes lacking the µ2 subunit are 579 
inactive and fail to localize to the plasma membrane (Meyer et al., 2000; Peden et al., 2002; 580 
Motley et al., 2003). To further investigate the importance of the Arc/AP-2 interaction, we 581 
designed shRNA-like sequences to knockdown the endogenous expression of µ2 in mouse 582 
tissue. We then used these shRNA constructs to transfect the mouse cell line NSC-34. A 583 
shRNA sequence, not predicted to knockdown any vertebrate genes, was used as a 584 
negative control. Using this approach we identified two out of three shRNA sequences (µ2-585 
shRNA2 and µ2-shRNA3) that efficiently reduced the protein expression of µ2 in NSC-34 586 
cells (Fig. 6a). To knockdown endogenous µ2 in neurons, we generated lentiviruses 587 
expressing these two shRNAs. The lentiviruses also express emGFP isocistronically, to 588 
efficiently identify the transduced neurons. Lentiviral transduction of µ2-shRNA2 into 589 
hippocampal cultures resulted in an overall 50% reduction in µ2 expression compared to the 590 
negative control shRNA (Fig. 6b). Note that even under optimal circumstances transduction 591 
rates in primary neurons are between 70-80% using lentiviral systems. This indicates that a 592 
significantly more pronounced reduction in µ2 expression has been achieved in those cells 593 
that have been transduced and used for recordings. To examine whether AP-2 is required in 594 
AMPAR-mediated synaptic transmission under basal conditions, we first transduced 595 
hippocampal cultures at 6-7 DIV with a lentivirus expressing µ2-shRNA2-emGFP and 596 
recorded AMPAR-mediated mEPSCs 7-8 days after transfection. No significant change in 597 
mEPSC amplitude was observed in cells expressing µ2-shRNA2 alone compared to 598 
untransfected neighboring cells (Fig. 6c(i)). These findings suggest that the constitutive 599 
endocytosis of AMPAR occurring under basal conditions in cultured hippocampal neurons is 600 
not strictly dependent on AP-2. 601 
To test whether AP-2 is required for Arc-mediated endocytosis of AMPAR, we recorded 602 
mEPSCs from hippocampal neurons expressing either µ2-shRNA2-emGFP- plus mCherry-603 
Arc-WT or the negative control (n.c.) shRNA-emGFP plus mCherry-Arc-WT as well as 604 
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untransfected neighboring neurons. Consistent with our hypothesis, a 30% reduction in 605 
mEPSC amplitudes was seen in neurons expressing Arc(WT) plus n.c. shRNA (Fig. 6d(i)). 606 
However this reduction in mEPSC amplitude was abolished in cells co-expressing Arc-WT 607 
plus µ2-shRNA2 (Fig. 6e(i)). Pooled data is displayed as cumulative probability distributions 608 
(Fig. 6f) and as bar charts plotting the mean amplitude and interval (Fig. 6g,h). To confirm 609 
this observation, we also recorded AMPAR-mediated mEPSCs from neurons expressing 610 
either µ2-shRNA3 alone or together with Arc-WT. Again, no change in mEPSC amplitudes 611 
was seen in cells expressing µ2-shRNA3 alone (Fig. 6i,j). However, expression of µ2-612 
shRNA3 blocked the Arc-WT-mediated decrease in mEPSC amplitudes (Fig. 6i-k). Neither 613 
mEPSC rise or decay kinetics was significantly affected by overexpression of either µ2-614 
shRNA2 or µ2-shRNA3 alone, Arc-WT plus µ2-shRNA2 or, µ2-shRNA3 or Arc(WT) plus n.c. 615 
shRNA (Fig. 5). These results demonstrate that knockdown of the AP-2 complex is sufficient 616 
to disrupt the Arc-mediated endocytosis of AMPAR. Together, these findings suggest that 617 
AP-2 is required for the Arc-mediated endocytosis of AMPAR in hippocampal neurons.  618 
 619 
Arc-mediated reduction in AMPAR-mediated mEPSC amplitude requires the binding of Arc 620 
to AP-2  621 
We have shown that: 1) the reduction in AMPAR-mediated mEPSC amplitude observed in 622 
neurons overexpressing Arc(WT) is either reduced or abolished in neurons expressing 623 
mutated Arc, that cannot bind to AP-2 (Fig. 4) and 2) that the effect of Arc-WT 624 
overexpression on mEPSC amplitude is reduced in neurons expressing a decreased amount 625 
of AP-2µ2 protein (Fig. 6). This data suggests that Arc requires AP-2 to facilitate the 626 
internalization of AMPAR. To confirm the functional relationship between Arc and AP-2, we 627 
recorded mEPSCs from hippocampal neurons expressing Arc-WT and µ2-shRNA2-emGFP 628 
in the same lentivirus combined with re-expression of µ2 using another lentivirus expressing 629 
a µ2-shRNA2 resistant µ2-mCherry fusion protein. As a control, lentiviruses encoding Arc(195-630 
199A)/µ2-shRNA2-emGFP and µ2-mCherry was used to transduce hippocampal cultures. As 631 
predicted, the Arc(WT)-mediated reduction in AMPAR mEPSC amplitude caused by depletion 632 
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of AP-2/µ2 (see Fig. 4) was reversed by overexpressing µ2 (Fig. 7a(i)), demonstrating that 633 
AP-2/µ2 is specifically required for the effect of Arc on AMPAR amplitudes. In contrast, no 634 
effect on AMPAR amplitudes was seen in cells expressing a mutant form of Arc(195-199A) that 635 
cannot bind to AP-2, irrespective of the expression status of µ2 (Fig. 7b(i), c). Pooled data is 636 
displayed as cumulative probability distributions (Fig. 7c) and as bar charts plotting the mean 637 
amplitude and interval (Fig. 7 d-e). Neither mEPSC rise or decay kinetics were significantly 638 
affected by overexpression of Arc-WT-µ2-shRNA2-emGFP plus µ2-mCherry and Arc(195-199A)-639 
µ2-shRNA2-emGFP plus µ2-mCherry (Fig. 5). These experiments clearly demonstrate that 640 
the Arc/AP-2 interaction is required for the reduction in AMPAR-mediated mEPSC 641 
amplitudes rather than sole disruption in AP-2. 642 
 643 
AP-2 is required for Arc-dependent homeostatic scaling 644 
Homeostatic scaling is the ability of neurons to sense the level of synaptic activity and 645 
compensate for changes by modulating their excitability. For example, in response to a 646 
prolonged increase in synaptic activity, neurons reduce synaptic strength by facilitating 647 
endocytosis of synaptic AMPAR (downscaling). Arc, whose expression is robustly induced 648 
by increased activity, is known to facilitate synaptic downscaling by enhancing AMPAR 649 
endocytosis (Shepherd et al., 2006; Mabb et al., 2014). Since we have shown that AP-2 is 650 
required for the Arc-dependent endocytosis of AMPA receptors, we hypothesized that a 651 
reduction in AP-2 expression should impair Arc-dependent synaptic scaling. To test this, we 652 
recorded AMPAR-mediated mEPSCs from hippocampal cultured neurons chronically treated 653 
with bicuculline (40 µM, 48 hr), which blocks inhibitory neurotransmission mediated by 654 
GABAA receptors and thus increases neuronal firing. In agreement with previous studies 655 
(Shepherd et al., 2006; Mabb et al., 2014), we observed a significant decrease in the 656 
amplitude of AMPAR-dependent mEPSCs in cells incubated with bicuculline compared to 657 
control cells (Fig. 8a-c). To address whether AP-2 was required for this reduction in mEPSC 658 
amplitude, we reduced µ2 expression by transducing hippocampal neurons with µ2-shRNA2, 659 
and as a control, n.c. shRNA, for 5 days prior to bicuculline incubation. In neurons 660 
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expressing the n.c. shRNA, bicuculline incubation still resulted in a robust reduction in 661 
mEPSC amplitude (Fig. 8b,c). However, the reduction in mEPSC amplitude was significantly 662 
smaller in neurons expressing µ2-shRNA2 (Fig. 8a-c). None of the treatments significantly 663 
(p>0.05) changed the frequency of mEPSCs (Fig. 8d) or the rise or decay kinetics of 664 
mEPSCs (Fig. 5). Together, these findings support the hypothesis that the Arc/AP-2 665 
interaction is required for the endocytosis of AMPAR during homeostatic scaling.  666 
 667 
Discussion 668 
The present study identifies a functional link between Arc and the AP-2 complex, a vital 669 
component of clathrin-mediated endocytic (CME) pathway. The AP-2 complex is required for 670 
selection and recruitment of the endocytic cargo and also for clathrin recruitment to the 671 
plasma membrane, processes that initiate the formation of the clathrin-coated pit (CCP) 672 
(Robinson, 2004; Saheki and De Camilli, 2012; Kelly et al., 2014; Kirchhausen et al., 2014). 673 
Here, we demonstrate that Arc immunoprecipitates with the AP-2 complex in hippocampal 674 
lysate and that Arc directly binds to the AP-2 complex (Fig. 1). We also show that the Arc 675 
residues 195QSWGP199 mediate the Arc/AP-2 association and that a conserved tryptophan 676 
residue at position 197 (W197) is essential for this interaction (Fig. 2). Importantly, the GST-677 
Arc mutants that is impaired in AP-2 binding still bound to another binding partner, Triad3A, 678 
demonstrating the structural integrity of the mutated Arc proteins. Interestingly, the mutated 679 
Arc proteins pulled down higher levels of Triad3A compared with GST-Arc(WT) from cell 680 
extracts (Fig. 2). While the reasons for these results were not addressed here, one possible 681 
explanation is that preventing the AP-2 interaction may render Arc´s C-terminal domain more 682 
accessible to make contacts with Triad3A, leading to increased binding. Importantly, this 683 
apparently higher affinity for the ubiquitin ligase Triad3A does not cause changes in the 684 
expression/stability of the Arc mutants (Fig. 3). This further demonstrates that the observed 685 
functional changes of the Arc mutants are specifically due to the loss of its binding to AP-2. 686 
In agreement with previous studies (Shepherd et al., 2006; Waung et al., 2008), we showed 687 
that overexpression of Arc strongly reduces surface expression of GluA1, but not GluA2 in 688 
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H4 neuroglioma cells (Fig. 3). In cultured hippocampal neurons, overexpression of Arc 689 
reduces the number of synaptic AMPA receptors, as shown by a decrease in the amplitude 690 
of AMPAR-mediated mEPSCs and also regulates AMPA receptor subunit composition (Fig. 691 
4). It has been previously shown that AMPA receptors containing GluA2 subunits show a 692 
linear current-voltage relationship in contrast to GluA2-lacking receptors that show 693 
pronounced rectification (Isaac et al., 2007). In our experiments, mEPSCs recorded from 694 
neurons overexpressing GFP alone showed pronounced rectification, suggesting that the 695 
predominant combination of AMPA receptors lacks the GluA2 subunit (also see Eales et al 696 
2014). In contrast overexpression of Arc resulted in diminished mEPSCs rectification, 697 
suggesting a reduction in the proportion of synaptic receptors that lack the GluA2 subunit. 698 
These findings are in agreement with previous studies showing that there is an increase in 699 
surface expression of GluA1, but not GluA2 subunits in hippocampal cultures obtained from 700 
Arc knockout mice at non-stimulated conditions (Shepherd et al., 2006). Also knockdown of 701 
endogenous Arc in hippocampal cultures resulted in increased GluA1 subunits at the surface 702 
at non-stimulated conditions (Waung et al., 2008). Furthermore, application of DHPG (which 703 
induces an increase in Arc translation and protein expression) to cultured hippocampal 704 
neurons reduced rectification (Eales et al., 2014). As expected, mutation of the AP-2 binding 705 
site in Arc or depletion of AP-2µ2 compromises the capacity of Arc to reduce AMPAR-706 
mediated mEPSC amplitudes (Figs. 4-6). Furthermore, the Arc-mediated reduction in 707 
AMPAR mEPSC amplitudes was rescued in cells where depletion of AP-2µ2 was reversed 708 
by re-introducing µ2 (Fig. 7). Importantly, this rescue was compromised in cells expressing a 709 
mutated form of Arc that cannot interact with AP-2 (Fig. 7). Furthermore, disruption of the 710 
Arc/AP-2 interaction by reducing the expression of AP-2µ2 also dampens the Arc-mediated 711 
reduction in synaptic strength observed in homeostatic synaptic downscaling (Fig. 8). 712 
Combined, these experiments demonstrate that Arc-dependent endocytosis of AMPARs 713 
requires an interaction of Arc with AP-2. It has been recently shown that dynamin activity is 714 
not required to reduce AMPA receptors surface levels induced by exposure to bicuculline 715 
and potassium chloride, suggesting that homeostatic downscaling may also be induced in a 716 
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clathrin-independent manner (Glebov, et al., 2014). Thus we cannot discard the possibility 717 
that AMPA receptor endocytosis via an as yet non-identified clathrin/dynamin independent 718 
mechanism may contribute to regulate synaptic strength seen in homeostatic synaptic 719 
downscaling. 720 
 721 
The requirement of Arc regulating synaptic plasticity in the hippocampus is well-established 722 
(Rial Verde et al., 2006; Bramham et al., 2010; Jakkamsetti et al., 2013; Mabb et al., 2014). 723 
However, to utilize Arc as a potential therapeutic target, it would be beneficial to obtain its 724 
crystal structure. During the development of this project, no information on Arc structure was 725 
available. As we have discovered that the interaction between Arc and AP-2 depends on a 726 
short motif in the Arc sequence (195-199), we have undertaken homology modelling studies 727 
using the iTASSER suite (http://zhanglab.ccmb.med.umich.edu/I-TASSER; Roy et al., 2010) 728 
to investigate the structural properties of this region and to obtain clues as to the structural 729 
nature of the interaction interface. Unfortunately we were not able to obtain a model with a 730 
reasonable confidence score. The main reason for this is that there are no other protein 731 
structures in the databank that are sufficiently related to Arc to allow modelling by homology 732 
approaches. Our attempts are in agreement with a recent study (Myrum et al., 2015) that 733 
also obtained models with low scores that were deemed to be only moderately reliable. In 734 
addition, the central region of the protein was suggested to be largely unstructured and 735 
flexible and the area containing the AP-2 interaction motif described in this study was not 736 
included in the models. Interestingly, another recent study (Zhang et al., 2015) has 737 
succeeded in obtaining a partial crystal structure of Arc, demonstrating that the C-terminal 738 
part of Arc is evolutionary similar to the Ty3/Gypsy retrotransposon and that it shows 739 
similarity to the HIV gag protein. However, the crystal obtained does not include the N-740 
terminal sequences up to amino acid 206 and therefore does not include the AP-2 binding 741 
motif. Nevertheless, as both studies (and our own modelling approach) suggested that the 742 
AP-2 binding motif is in a flexible and at least partly unstructured region of the protein, it is 743 
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highly likely that this region of Arc is able to serve as a binding platform for multiple partners, 744 
including AP-2. 745 
 746 
Arc has been shown to mediate endocytosis of AMPAR via interaction with dynamin 2 and 747 
endophilin 3, which are accessory proteins of the CME machinery (Chowdhury et al., 2006). 748 
Endophilin and dynamin are required for membrane constriction and scission of the CCV, 749 
which are late events in the CME process. Recent evidence, using mature cultured cortical 750 
neurons from distinct knockout mice where specific endophilins have been knocked out, 751 
clearly demonstrated that the assembly and early maturation events of clathrin-coated pit 752 
formation are independent of endophilin (Milosevic et al., 2011). Dynamin is recruited at late 753 
stages of endocytosis and its enrichment coincides with neck fission and release of the 754 
vesicle (Ferguson and De Camilli, 2012; Grassart et al., 2014). These findings clearly 755 
demonstrate that endophilin and dynamin do not participate in the cargo selection process. 756 
In contrast, AP-2 plays a critical role in the initiation of clathrin-mediated endocytosis, as it 757 
coordinates the cargo recruitment and selection together with clathrin recruitment and lattice 758 
assembly (Robinson, 2004; Kirchhausen et al., 2014; Kelly et al., 2014). The AP-2 complex 759 
is thought to exist in an inactive “closed” conformation in the cytosol that prevents 760 
unproductive interaction with clathrin. Binding to plasma membrane enriched 761 
phosphatidylinositol-4,5-bisphosphate [PtdIns(4,5)P2] and to transmembrane cargo, triggers 762 
conformational changes in AP-2 that are necessary to allow efficient binding to clathrin and 763 
bud formation which is thought to be the dominant mechanism for the initiation of clathrin 764 
coat assembly (Kelly et al., 2014). The current model, in which Arc is able to induce clathrin-765 
mediated AMPAR endocytosis via interaction with endophilin and dynamin, does not place 766 
Arc as a decisive player in specifically controlling excitatory synaptic transmission. 767 
Importantly, our finding that Arc directly binds to AP-2 provides the mechanistic link by which 768 
activity-dependent expression of Arc specifically facilitates endocytosis of AMPAR. We 769 
therefore suggest a refined model where neuronal excitability induces an increase in Arc 770 
protein expression in dendritic spines (Fig. 9). Newly expressed Arc then interacts with AP-2 771 
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and possibly increases its affinity for the cytosolic tail of AMPA receptors. Activated AP-2 772 
initiates the formation of the clathrin-mediated pits (CMP) by coordinating the assembly of 773 
clathrin and binding to AMPAR at the postsynaptic density. We speculate that following the 774 
formation of CMP, Arc then binds and recruits endophilin and dynamin, which trigger fission 775 
of the vesicle neck. Arc may not be able to simultaneously bind to AP-2 and 776 
endophilin/dynamin. Therefore, one possible explanation is that following CMP formation, 777 
the affinity between Arc and AP-2 is reduced, releasing Arc from the CMP. The unbound Arc 778 
then binds and recruits endophilin and dynamin, which promotes neck fission and release of 779 
the CCV. Alternatively, Arc binding to dynamin/endophilin may be facilitated through AP-2 780 
interacting partners such as amphiphysin, which is able to bind to both AP-2 and dynamin 781 
(Slepnev et al., 2000). In fact, AP-2 has been described as a major hub for recruitment of 782 
accessory proteins to the maturing CMP (Schmid et al., 2006; McMahon and Boucrot, 2011). 783 
Our discovery that Arc directly binds to AP-2, which in turn regulates AMPAR endocytosis, 784 
provides the crucial mechanistic link explaining how activity-dependent expression of Arc 785 
regulates synaptic plasticity and therefore plays a critical role in learning and memory 786 
formation.  787 
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 930 
Figure Legends 931 
Figure 1. Arc directly interacts with the AP-2 complex. 932 
(a) Arc co-immunoprecipitates with the α subunit of AP-2. Hippocampal lysate was subjected 933 
to immunoprecipitation (IP) with an Arc antibody followed by immunoblot (IB) using an anti-α 934 
adaptin antibody. Ten percent of the protein lysate used for the IP was loaded in the input 935 
lane. (b) Arc co-immunoprecipitates with clathrin in hippocampal lysate. Hippocampal lysate 936 
was subjected to immunoprecipitation (IP) with a rabbit anti-Arc or a normal rabbit anti-IgG 937 
control antibodies followed by immunoblot (IB) using an anti-α adaptin and an anti-clathrin 938 
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heavy chain antibodies. Ten percent of the protein lysate used for the IP was loaded in the 939 
input lane. (c-d) Pull-down assay showing the interaction of AP-2 core with mouse Arc(WT). 940 
Recombinant affinity purified GST-AP-2 core (GST tagged α subunit (residues 1-621), 6xHis 941 
tagged β2 subunit (residues 1-591), full length µ2 and σ2 subunits), was immobilized on 942 
glutathione beads (c, right panel) and incubated with recombinant affinity purified 6xHis-943 
Arc(WT) (c, left panel). Binding of Arc protein to GST-tagged AP-2 core or GST alone was 944 
analysed by GST pull-down and SDS-PAGE, followed by Coomassie blue staining (d, left 945 
panel) or immunoblot using an anti-Arc antibody (d, right panel). (e) Schematic 946 
representation of the Arc-WT sequence showing the truncated Arc mutants used in this 947 
study. The diagram indicates coiled-coil (CC) and spectrin repeat homology (SRH) structure 948 
domain of mouse Arc. AP-2 binding site is shown in black. (f) Pull-down assay showing the 949 
interaction of AP-2 core with mouse Arc(WT) and the Arc(1-199) truncated (deletion of residues 950 
200-396). Recombinant affinity purified AP-2 core, was immobilized on glutathione beads 951 
and incubated with lysates of E. coli expressing Arc(WT) or Arc(1-199) deletion mutant. Binding 952 
of Arc proteins to GST-tagged AP-2 or GST alone was analysed by GST pull-down and 953 
SDS-PAGE, followed by Coomassie blue staining (left panel) or immunoblot using an anti-954 
His tag antibody (right panel). Ten percent of the recombinant proteins used for the pull-955 
down was loaded on the input lane (Bands corresponding to Arc proteins are indicated by 956 
white asterisks). (g) Pull-down assay showing that the Arc residues 195-199 are required for 957 
the Arc/AP-2 interaction as truncated Arc(1-194) produced in E. coli lost the ability to bind 958 
immobilised recombinant GST-tagged AP-2 core. 959 
Figure 2: Identification of Arc motif that binds to AP-2. 960 
(a) Pull-down assay showing that a conserved tryptophan residue at position 197 mediates 961 
Arc/AP-2 interaction. Recombinant GST-Arc(WT), GST-Arc(W197A), GST-Arc(195-199A) or GST 962 
alone were produced in E. coli and immobilized on glutathione beads (bottom) and incubated 963 
with total brain tissue lysate. Binding of endogenous µ2 and α-adaptins to GST fusion 964 
proteins was analysed by SDS-PAGE immunoblotting with anti-µ2 (top) or anti-α (middle) 965 
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antibodies. Bar chart plotting analysis of the relative amount of protein bound to GST and 966 
GST-Arc(W197A) and GST-Arc(195-199A) normalized to GST-ArcWT (100%). (b) Pull-down assay 967 
showing interaction of Arc(WT) and Arc(W197A) with dynamin 2. Recombinant GST-Arc(WT), GST-968 
Arc(W197A) or GST alone were produced in E. coli, immobilized on glutathione beads (bottom) 969 
and incubated with total lysates of HEK293 cells expressing dynamin 2-GFP. Binding of 970 
dynamin 2-GFP to GST fusion proteins was analysed by SDS-PAGE immunoblotting with 971 
anti-GFP antibody (top). Bar chart plotting analysis of the relative amount of dynamin 2 972 
bound on the beads normalized to GST-ArcWT (100%). 10% of total protein lysate used to 973 
incubate the beads was used as input. (c) Pull-down assay showing interaction of Arc(WT), 974 
Arc(W197A) and GST-Arc(195-199A) with Triad3A. Recombinant GST proteins produced in E. coli 975 
and immobilized on glutathione beads (bottom) were incubated with total lysates of HEK293 976 
cells expressing GFP-Triad3A. Binding of GFP-Triad3A to GST fusion proteins was analyzed 977 
by SDS-PAGE immunoblotting with anti-GFP antibody (top). Bar chart plotting analysis of 978 
the relative amount of Triad3A bound on the beads normalized to GST-ArcWT (100%). 10% 979 
of total protein lysate used to incubate the beads was used as input. Errors bars represent 980 
the means ± SEM (n = 3 independent experiments). *p<0.05, **p<0.005 and ***p<0.0005 981 
using unpaired Student´s t test. 982 
Figure 3. Arc/AP-2 interaction regulates GluA1 endocytosis   983 
(a,b) Representative blots showing that Arc(WT), but not the Arc(W197A) mutant, facilitates 984 
GluA1, but not GluA2 endocytosis. H4 neuroglioma cells were transfected with plasmids 985 
encoding myc-GluA1 (a) or myc-GluA2 (b) in combination with either: empty pCIneo vector, 986 
pCIneo Arc(WT) or pCIneo Arc(W197A). Western blot band densitometry analysis showing that: 987 
(a) Arc(WT), but not Arc(W197A),  promotes a significant reduction in surface expression of GluA1 988 
subunits (control: 60.46 ± 2.97%; Arc(WT): 38.55 ± 7.44%; Arc(W197A): 50.18 ± 8.34%. Error 989 
bars represent the means ± SEM (n = 3 independent experiments). *p<0.05 using one-way 990 
ANOVA followed by Tukey´s post-test. (b) Arc(WT) does not promote any changes in surface 991 
expression of either GluA2 subunits (control: 132.9 ± 26.66%; Arc(WT): 133.2 ± 21,78%; 992 
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Arc(W197A): 143.9 ± 38.43%) or EGF receptor (control: 51.35 ± 10.43%; Arc(WT): 38.93 ± 993 
8,66%; Arc(W197A): 41.59 ± 8.8%). Error bars represent the means ± SEM (n = 4 independent 994 
experiments).Ten percent of the protein lysate used for incubate the beads was loaded in 995 
the input lane. GAPDH was used as loading controls. (c-f) H4 cells co-expressing myc-996 
GluA1 with either mCherry construct alone (c); mCherry-Arc(WT) (d); or mCherry-Arc(W197A) 997 
(e). Surface myc-GluA1 (non-permeabilized cells, green channel) was identified using 998 
mouse anti-myc antibody followed by Alexa 488 secondary antibody and internal myc-GluA1 999 
(permeabilized, magenta channel) was identified by polyclonal rabbit anti-myc antibody 1000 
followed by Alexa 647 secondary antibody. (f,g) The mean florescence intensity (MFI) of 1001 
Alexa488 (surface my-GluA1) and mCherry (red channel) were calculated using confocal Z-1002 
projection images to quantify the pixel intensity of surface myc-GluA1 and mCherry (total 1003 
protein expression). (f) Ratio of averaged MFI between surface (488)/total protein (mCherry) 1004 
for control cells (n=59 cells) was set to 100 % to facilitate comparison. Note that the ratio for 1005 
surface GluA1 is significantly reduced in cells expressing mCherry-Arc(WT) 34,68 ± 3,13%; n= 1006 
60 cells) compared to cells expressing mCherry construct alone. Importantly, this reduction 1007 
is absent in cells expressing the mCherry-Arc(W197A) construct (114,80 ± 13,08%; n= 42 cells. 1008 
(g) Bar chart plotting the averaged MFI expression levels of mCherry-Arc(WT) and mCherry-1009 
Arc(W197A) compared to mCherry expression. Values are the mean ± SEM (n=3 independent 1010 
experiments). *p<0.05; ***p<0.005 using one-way ANOVA followed by Tukey´s posttest. 1011 
Scale bar=10 μm. (h) Representative blot and bar chart plotting bands densitometry analysis 1012 
of Arc expression protein in H4 cells transfected with equal amounts of mCherry-Arc(WT), 1013 
mCherry-Arc(W197A),or mCherry-Arc(195-199A) plasmids. Note the similar levels Arc protein 1014 
expression between samples. Values are the mean ± SEM (n=3 independent experiments). 1015 
Figure 4. The Arc/AP-2 interaction regulates AMPAR-mediated synaptic currents 1016 
(a-d) Representative live imaging of a dissociated hippocampal neuron overexpressing Arc-1017 
GFP-tagged constructs and GFP. (a) AMPAR-mediated mEPSC traces from a neuron 1018 
overexpressing Arc(WT) and an untransfected neighboring neuron. (ai) Amplitude probability 1019 
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distribution for the mEPSCs shown in (a). Note the shift to the left and increase in the 1020 
amplitude of the main peak in the neuron overexpressing Arc(WT), clearly demonstrating the 1021 
reduction in mEPSC amplitude. Inset, superimposed average mEPSC waveforms. (b) 1022 
Representative AMPAR-mediated mEPSC traces from a neuron overexpressing GFP and 1023 
an untransfected neighboring neuron. (bi) Amplitude probability distributions for mEPSCs 1024 
recorded from the neurons shown in (b). Inset, superimposed average mEPSC waveforms. 1025 
(c) Representative AMPAR-mediated mEPSC traces from a neuron expressing Arc(W197A) 1026 
and an untransfected neighbouring neuron. (ci) Amplitude probability distributions from 1027 
neurons shown in (c). Note that expression of Arc(W197A) produced a smaller reduction in 1028 
mEPSC amplitude compared to Arc(WT) overexpression. Inset, superimposed average 1029 
mEPSC waveforms. (d) Representative AMPAR-mediated mEPSC traces from a neuron 1030 
expressing Arc(195-199A) and an untransfected neighboring neuron. (di) Amplitude probability 1031 
distributions from neurons shown in (d). Note that expression of Arc(195-199A), in which the 1032 
sequence 195QSWGP199 of Arc was mutated to 195AAAAA199 had little effect on mEPSC 1033 
amplitude. Inset, superimposed average mEPSC waveforms. (e) Cumulative probability 1034 
distributions for cells expressing Arc(WT) (12 neurons), Arc(W197A) (13 neurons), Arc(195-199A) (10 1035 
neurons), GFP (7 neurons) and for untransfected cells (20 neurons). (f), Bar chart plotting 1036 
mean mEPSC amplitude for the cells in (e). Expression of Arc(WT) significantly reduced 1037 
mEPSC amplitude (mean reduced from 15.99 ± 0.9 pA in untransfected cells to 10.56 ± 0.66 1038 
pA, p= 0.0002) whereas expression of Arc(W197A) or Arc(195-199A) had no significant effect (14.6 1039 
± 0.74 pA, p=0.12 and 14.01 ± 1.2 pA, p= 0.37). Expression of eGFP had no significant 1040 
effect (p=0.376) on the mean mEPSC amplitude compared to untransfected cells. (g) Bar 1041 
chart plotting the mean interval between mEPSCs. Expression of Arc(WT) and the Arc 1042 
mutants had no significant effect on the frequency of mEPSCs. Although the mean 1043 
frequency of mEPSCs in cells expression Arc(WT) appeared reduced, this was not significant 1044 
as there was large variability between cells. (h) Representative average mEPSC waveforms 1045 
recorded at a holding potential of -60 and + 40 mV for cells expressing GFP, Arc(WT) and 1046 
Arc(W197A) in the presence of spermine (100 µM) in the intracellular solution. (i) Bar chart 1047 
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plotting the mean rectification index (peak amplitude at + 40 mV divided by peak amplitude 1048 
at -60 mV) for neurons expressing GFP (n = 9 cells; 0.34 ± 0.015), Arc(WT) (n = 9 cells; 0.62 ± 1049 
0.016) and Arc(W197A) (n = 6 cells; 0.45 ± 0.015). Thus Arc(WT) reduces the amount of 1050 
rectification (as seen as an increase in the rectification index) whereas Arc(W197A) has 1051 
significantly less effect on rectification. Error bars in f, g and i are SEMs ***p<0.001; 1052 
**p<0.01. Statistical significance was tested using the Mann-Whitney test. Scale bar=10 µm 1053 
Figure 5. Overexpression of Arc-cDNAs does not affect AMPAR-mediated mEPSC 1054 
kinetics in hippocampal neurons  1055 
(a) Average of 75 miniature excitatory postsynaptic currents (mEPSCs, aligned on the mid-1056 
point of the rising phase) from an individual neuron expressing Arc(WT). The decay was fitted 1057 
with a single exponential (τ = 4.5 ms, black line). Inset: the average mEPSC at an expanded 1058 
time-base showing the exponential fit to the decay. (b) Average of 80 mEPSCs (aligned on 1059 
the mid-point of the rising phase) from an untransfected neuron which was a close neighbour 1060 
to the cell in (A).The decay of the mEPSC was very similar to the transfected neighbour (the 1061 
decay was fitted with a single exponential; τ = 4.7 ms, black line). Inset: the average mEPSC 1062 
at an expanded time-base to show the exponential fit to the decay. (c) Bar chart plotting the 1063 
mean 10-90 % rise-time of mEPSCs recorded from untransfected neurons (n= 18) and from 1064 
neurons expressing different constructs and in different conditions (n = 6 for each). The 1065 
mean rise-time was calculated by averaging the rise-time of mean currents from individual 1066 
recordings. There was no significant difference in the mean mEPSC rise-time recorded from 1067 
any of the neurons. (d) Bar chart plotting the mean decay time constant (τ) from 1068 
untransfected neurons (n=18) and from neurons expressing different constructs and in 1069 
different conditions (n=6 for each). The mean decay time constant (τ) was calculated by 1070 
averaging the time constant from the decay of mean currents from individual recordings. The 1071 
decay of mEPSCs was not significantly different between conditions. The error bars in (c) 1072 
and (d) are SEMs. Statistical significance was tested using the Mann-Whitney test 1073 
Figure 6. AP-2 is required for Arc-dependent changes in synaptic strength 1074 
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(a) Blots showing levels of µ2 protein obtained from NSC cells overexpressing negative 1075 
control (n.c.) shRNA, µ2-shRNA2, µ2-shRNA3 plasmids for 3-4 days. GAPDH was used as 1076 
loading control. Bar chart plotting the analysis of µ2 band intensity normalised by GAPDH. 1077 
Error bars indicate ± SEM and significance was tested using one-way ANOVA ***p=0.0001. 1078 
(b) Blots showing levels of µ2 protein obtained from cultured hippocampal neurons infected 1079 
for 8-9 days with lentiviruses expressing either µ2-nc shRNA or µ2-shRNA2 sequences for 8-1080 
9 days. GAPDH was used as loading control. Bar chart plotting the analysis of µ2 band 1081 
intensity normalised by GAPDH intensity. Error bars indicate ± SEM and significance was 1082 
tested using One-Way ANOVA, *p=0.019. (c) Representative AMPAR-mediated mEPSC 1083 
traces from a neuron expressing µ2-shRNA2 and an untransfected neighbour. (ci) Amplitude 1084 
probability distributions from the neuron shown in (c). Note that reduction of AP-2 expression 1085 
(µ2-shRNA2) has little effect on mEPSC amplitude. Inset, superimposed average mEPSC 1086 
waveforms. (d) Representative AMPAR-mediated mEPSC traces from a neuron co-1087 
expressing Arc(WT) and nc shRNA and an untransfected neighbour. (di) Amplitude probability 1088 
distribution from the neurons in (d). Note that co-expression of a n.c. shRNA does not 1089 
prevent overexpression of Arc from reducing mEPSC amplitude. Inset, superimposed 1090 
average mEPSC waveforms. (e) Representative AMPAR-mediated mEPSC traces from a 1091 
neuron co-expressing Arc(WT) and µ2-shRNA2 and an untransfected neighbor. (e(i)) 1092 
Amplitude probability distribution from the neurons showed in (e). Note that co-expression of 1093 
µ2-shRNA2 prevents the effects of Arc(WT) on mEPSC amplitude. Inset, superimposed 1094 
average mEPSC waveforms. (f) Cumulative probability distributions for cells expressing 1095 
shRNA2 (9 neurons), Arc(WT) + shRNA2 (16 neurons), Arc(WT)+n.c shRNA (7 neurons), and for 1096 
untransfected cells (12 neurons). (g) Bar chart plotting mean mEPSC amplitude for the cells 1097 
in (f). Expression of shRNA2 prevented the Arc(WT) overexpression effect of significantly 1098 
reducing mEPSC amplitude (mean mEPSC amplitude 15.3 ± 1 pA in untransfected cells, 1099 
Arc(WT) + shRNA2 14.3 ± 0.8 pA, p=0.52). Expression of shRNA2 alone had no significant 1100 
effect on mEPSC amplitude (13 ± 0.7 pA, p=0.07) whereas Arc(WT) + n.c. shRNA significantly 1101 
reduced mEPSC amplitude (10.2 ± 0.53 pA, p=0.001). (h) Bar chart plotting the mean 1102 
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interval between mEPSCs for the cells in (f). The error bars in (g) and (h) are SEMs 1103 
***p<0.001; **p<0.005. Statistical significance was tested using the Mann-Whitney test. (i) 1104 
Amplitude probability distributions for a neuron expressing µ2-shRNA3 and an untransfected 1105 
neighbour and for a neuron overexpressing Arc(WT) with µ2-shRNA3 and an untransfected 1106 
neighbour (j). Inset, superimposed average mEPSC waveforms. (k) Bar chart of mean 1107 
mEPSC amplitudes for untransfected cells (n = 8), cells transfected with μ2-shRNA3 (n=10) 1108 
and cells transfected with Arc(WT)+ μ2-shRNA3 (n=6). Neither expression of μ2-shRNA3 or 1109 
Arc(WT)+μ2-shRNA3 significantly changed mEPSC amplitude (p=0.68 and p=0.27 1110 
respectively).   1111 
Figure 7. Arc/AP-2µ interaction is required for the Arc-mediated reduction in AMPAR 1112 
mEPSC amplitude 1113 
(a) Representative AMPAR-mediated mEPSC traces from a neuron expressing Arc(WT)+µ2-1114 
shRNA2+µ2 and an untransfected neighboring neuron. (ai) Amplitude probability distributions 1115 
from the neurons showed in (a). Note that re-introduction of µ2 rescued the effect of Arc(WT) 1116 
overexpression leading to a reduction in the amplitude of mEPSC amplitudes (shift to the 1117 
left, red trace). Inset, superimposed average mEPSC waveforms. (b) Representative 1118 
AMPAR-mediated mEPSC traces from a neuron expressing Arc(195-199A)+µ2-shRNA2+µ2 and 1119 
an untransfected neighboring neuron. (bi) Amplitude probability distributions from the 1120 
neurons showed in (d). Note that re-introduction of µ2 has little effect in mEPSC amplitude 1121 
(no shifts between black and red traces). Inset, superimposed average mEPSC waveforms. 1122 
(c) Cumulative probability distributions for cells expressing Arc(WT) +μ2-shRNA2 +μ2  (14 1123 
neurons), Arc(195-199A) +μ2-shRNA2 +μ2 (9 neurons) and untransfected cells (14 neurons). (d) 1124 
Bar chart plotting mean mEPSC amplitude for the cells in (c). Expression of μ2 rescued the 1125 
reduction in mEPSC amplitude produced by Arc(WT) overexpression, following the 1126 
knockdown of AP-2 by shRNA2 (mean mEPSC amplitude in untransfected cells 16.9 ± 1.3 1127 
pA vs 10.1 ± 0.6 pA in cells expressing Arc(WT) +μ2-shRNA2 +μ2, p=0.0001). In contrast, 1128 
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expression of μ2 had no significant effect on mEPSC amplitude when Arc(195-199A), which 1129 
does not interact with AP2, was expressed together with shRNA2 (15.9 ± 1.7 pA, p = 0.46). 1130 
(e) Bar chart plotting the mean interval between mEPSCs for the cells in (c). The error bars 1131 
in (d) and (e) are SEMs ***p<0.001; **p<0.01. Statistical significance was tested using the 1132 
Mann-Whitney test.  1133 
Figure 8. AP-2 is required for Arc-dependent homeostatic scaling 1134 
(a) Average mEPSC waveforms from an untransfected neuron cultured in control conditions, 1135 
from an untransfected neuron exposed to bicuculline and from a µ2-shRNA2 expressing 1136 
neuron that has been incubated in bicuculline (40 µM; 48 hr). Note that the bicuculline-1137 
induced down regulation of the mEPSC amplitude was reduced in AP-2 depleted cells (µ2-1138 
shRNA2 expressing cells).The untransfected neuron and the neuron expressing µ2-shRNA2 1139 
that were cultured in the presence of bicuculline were neighbors in the same dish, while the 1140 
untransfected neuron cultured in control conditions was from the same preparation. (b) 1141 
Cumulative amplitude distribution for untransfected neurons cultured in control conditions 1142 
(black line, n=10 neurons), untransfected neurons incubated in bicuculline (red line, n=15 1143 
neurons), µ2-shRNA2 expressing cells incubated in bicuculline (blue line, n=6 neurons) and 1144 
cells transfected with n.c. shRNA incubated in bicuculline (green line, n=5 neurons). (c) Bar 1145 
chart plotting the mean mEPSC amplitude for the cells shown in (b). Incubation in bicuculline 1146 
significantly reduced the mean mEPSC amplitude (from 17.3 ± 1 pA to 11.9 ± 0.2 pA, 1147 
p=0.0001). Expression of shRNA2 significantly increased mEPSC amplitude in bicuculline 1148 
(14.38 ± 0.16 pA, p=0.0001) whereas n.c shRNA had significantly less effect (12.9 ± 0.28 1149 
pA, p=0.007). (d) Bar chart plotting the mean interval between mEPSCs for the cells in (b 1150 
and c). The error bars in (c) and (d) are SEMs ***p<0.001; **p<0.01. Statistical significance 1151 
was tested using the Mann-Whitney test. 1152 
Figure 9. Arc/AP-2 interaction controls synaptic strength.  1153 
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The proposed model showing the mechanism by which Arc/AP-2 interaction facilitates 1154 
AMPAR endocytosis. An increase in neuronal activity promotes rapid Arc mRNA translation 1155 
and protein expression at the dendritic spines. (1) Newly expressed Arc binds to the AP-2 1156 
complex and may activate/facilitate AP-2 interaction with AMPAR at the plasma membrane. 1157 
(2) To initiate the formation of the clathrin-coated assembly AP-2 binds and recruits clathrin 1158 
to the membrane. (3-4) Arc then binds and recruits endophilin and dynamin to promote 1159 
scission of the endocytic vesicle containing the AMPAR to be targeted for either recycling or 1160 
degradation. 1161 
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Table1: Statistical Analyses  
 
 
Results Data 
Structure  
Type of 
Test 
n  
numbers 
Probability 
(P) 
(Fig. 2a, top panel) 
IB pulldown α 
GST-Arc(WT) vs GST  
Two factor, 
mean 
 
t test 3/3 < 0.0001 
GST-Arc(WT) vs GST-Arc(W197A) 
Two factor, 
mean 
t test 3/3 < 0.0001 
GST-Arc(WT) vs GST-Arc(195-199A) 
Two factor, 
mean 
 
t test 3/3 < 0.0001 
(Fig. 2a, middle 
panel) IB pulldown 
µ2 
GST vs GST-Arc(WT) 
Two factor, 
mean 
 
t test 3/3 < 0.0001 
GST-Arc(WT) vs GST-Arc(W197A) 
Two factor, 
mean 
 
t test 3/3 0.0007 
GST-Arc(WT) vs GST-Arc(195-199A) 
Two factor, 
mean 
t test 3/3 0.0039 
(Fig. 2b) IB 
pulldown dyn2-
GFP 
GST-Arc(WT) vs GST 
Two factor, 
mean 
 
t test 3/3 < 0.0001 
GST-Arc(WT) vs GST-Arc(W197A) Two factor, 
mean 
 
t test 3/3 0.0159 
(Fig. 2c) IB 
pulldown GFP-
Triad3A 
GST-Arc(WT) vs GST  
Two factor, 
mean 
 
t test 3/3 < 0.0001 
GST-Arc(WT) vs GST-Arc(W197A) 
Two factor, 
mean 
 
t test 3/3 0.0055 
GST-Arc(WT) vs GST-Arc(195-199A) 
Two factor, 
mean 
 
t test 3/3 0.0055 
(Fig. 3a) IB Surface 
GluA1 
pCIneo vs pArc(WT) Two factor, 
mean 
ANOVA 
Tukey’s 
3/3 0.1284 
pCIneo vs pArc(W197A) Two factor, 
mean 
 
ANOVA 
Tukey’s 
4/4 0.5543 
(Fig. 3b) IB Surface 
GluA2 
pCIneo vs pArc(WT) Two factor, 
mean 
 
ANOVA 
Tukey’s 
4/4 >0.9999 
pCIneo vs pArc(W197A) Two factor, 
mean 
 
ANOVA 
Tukey’s 
4/4 0.9637 
(Fig. 3b) IB Surface 
EGFR 
pCIneo vs pArc(WT) Two factor, 
mean 
 
ANOVA 
Tukey’s 
4/4 0.6156 
pCIneo vs pArc(W197A) Two factor, 
mean 
 
ANOVA 
Tukey’s 
4/4 0.7621 
  2
(Fig. 3f) IF Surface 
GluA1 
mCherry vs  
mCherry-Arc(WT) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
59/60 <0.0001 
mCherry vs  
mCherry-Arc(W197A) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
59/42 0.3438 
(Fig. 3g) IF 
mCherry expression 
mCherry vs  
mCherry-Arc(WT) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
3/3 0.5625 
mCherry vs  
mCherry-Arc(W197A) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
3/3 0.9211 
(Fig. 3h) IB Arc 
expression 
mCherry-Arc(WT) vs  
mCherry- Arc(W197A) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
3/3 0.6892 
mCherry-Arc(WT) vs  
mCherry- Arc(195-199A) 
Two factor, 
mean 
 
ANOVA 
Tukey’s 
3/3 0.4951 
 
(Fig. 4) Arc/AP-2 
interaction 
 
 
 
 
 
 
 
 
Arc(WT) vs untransfected 
amplitude  
frequency 
Two factor, 
mean 
  
Mann 
Whitney  
12/20  
0.0002 
0.47 
Arc(W197A) vs untransfected 
amplitude  
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
13/20  
0.121 
0.98 
Arc(195-199A) vs untransfected 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
10/20  
0.372 
0.18 
eGFP vs untransfected  
amplitude  
frequency  
Two factor, 
mean 
 
Mann 
Whitney 
7/20  
0.376 
0.39 
(Fig. 5) 
 cDNA 
constructs and  
mEPSC kinetics 
All constructs vs untransfected 
rise  
decay  
Two factor, 
mean 
 
Mann 
Whitney 
6/18  
>0.05 
>0.05 
(Fig. 6)  
AP-2 requirement 
for Arc mediated 
changes in synaptic 
strength 
μ2-miRNA2 vs untransfected 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
9/12  
0.07 
0.37 
Arc(WT) + μ2-miRNA2 vs 
untransfected 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
16/12  
 
0.52 
0.63 
Arc(WT) + n.c.miRNA vs 
untransfected  
amplitude  
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
7/12  
 
0.001 
0.08 
μ2-miRNA3 vs untransfected  
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
10/8  
0.68 
0.45 
Arc(WT) + μ2-miRNA3 vs 
untransfected 
amplitude  
frequency  
Two factor, 
mean 
 
Mann 
Whitney 
6/8  
 
0.27 
0.14 
(Fig. 7)  
The Arc-AP-2μ 
interaction is 
required for Arc-
mediated changes 
in synaptic strength 
Arc(WT) +μ2-miRNA2+μ2 vs 
untransfected  
amplitude  
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
14/14  
 
0.0001 
0.37 
Arc(195-199A)+μ2-miRNA2+μ2 vs 
untransfected  
amplitude 
Two factor, 
mean 
 
Mann 
Whitney 
9/14  
 
0.46 
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frequency 0.64 
(Fig. 8)  
AP-2 is required for 
homeostatic 
scaling. 
Control vs bicuculline 
(untransfected) 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
10/15  
 
0.0001 
0.64 
miRNA2 (bicuculline) vs 
untransfected (bicuculline) 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
6/15  
 
0.0001 
0.59 
n.c.miRNA (bicuculline) vs 
untransfected 
amplitude 
frequency 
Two factor, 
mean 
 
Mann 
Whitney 
5/15  
 
0.007 
0.29 
 
